BCMA in Multiple Myeloma—A Promising Key to Therapy

BCMA in Multiple Myeloma—A Promising Key to Therapy

Despite the discoveries of numerous agents including next generation proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies, multiple myeloma (MM) remains an incurable disease. The field of myeloma treatment in refractory or relapsed patients after standard therapy entered a new er...

Full description

Bibliographic Details
Main Authors: Martina Kleber, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Clinical Medicine
Subjects:
BCMA
multiple myeloma
antibody
conjugated
BiTE
ADC
Online Access:https://www.mdpi.com/2077-0383/10/18/4088

Similar Items

Similar Items